These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17567634)

  • 21. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in rheumatoid arthritis patients in South India.
    Mathew AJ; Antony J; Eremenco S; Paul BV; Jayakumar B; Philip J
    Singapore Med J; 2009 Aug; 50(8):800-3. PubMed ID: 19710980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P; Esselens G; Westhovens R
    Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic quality-of-life assessment in rheumatoid arthritis.
    Tugwell P; Idzerda L; Wells GA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S224-36. PubMed ID: 18095786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
    Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
    Ward MM; Fries JF
    J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years.
    Wallenius M; Skomsvoll JF; Koldingsnes W; Rødevand E; Mikkelsen K; Kaufmann C; Kvien TK
    Scand J Rheumatol; 2009; 38(3):178-83. PubMed ID: 18991183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data.
    Kobelt G; Lindgren P; Geborek P
    Scand J Rheumatol; 2009; 38(6):409-18. PubMed ID: 19922015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
    Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
    Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment.
    Veehof MM; ten Klooster PM; Taal E; van Riel PL; van de Laar MA
    Ann Rheum Dis; 2008 Jun; 67(6):789-93. PubMed ID: 17974597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists.
    Sany J; Bourgeois P; Saraux A; Durieux S; Lafuma A; Daurès JP; Guillemin F; Sibilia J
    Ann Rheum Dis; 2004 Oct; 63(10):1235-40. PubMed ID: 15361378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How may quality of life for rheumatoid arthritis patients be enhanced by current and future treatments?
    Fries JF
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():35-40. PubMed ID: 10646489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.
    Teng YK; Verburg RJ; Sont JK; van den Hout WB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2005 Aug; 52(8):2272-6. PubMed ID: 16052541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.
    Kahn KL; Maclean CH; Wong AL; Rubenstein LZ; Liu H; Fitzpatrick DM; Harker JO; Chen WP; Traina SB; Mittman BS; Hahn BH; Paulus HE
    Arthritis Rheum; 2007 Jun; 57(5):707-15. PubMed ID: 17530663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
    van Riel PL; Freundlich B; MacPeek D; Pedersen R; Foehl JR; Singh A;
    Ann Rheum Dis; 2008 Aug; 67(8):1104-10. PubMed ID: 17666447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
    Odegård S; Kvien TK; Uhlig T
    J Rheumatol; 2008 Jan; 35(1):54-60. PubMed ID: 18050381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
    Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
    Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can severity be predicted by treatment variables in rheumatoid arthritis administrative data bases?
    Wolfe F; Michaud K; Simon T
    J Rheumatol; 2006 Oct; 33(10):1952-6. PubMed ID: 16960927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.